Ivan Nikolaev - Novartis Pharma AG | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 41 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

54117 Disease Journey and Treatment Outcomes: the Real-World Experience of Patients with CSU

Jonathan Bernstein, Tonya A. Winders,Ivan Nikolaev,Maria-Magdalena Balp, Tara Raftery, Pallavi Saraswat, Jessica McCarthy,Merin Kuruvilla, Karsten Weller

Journal of the American Academy of Dermatology（2024）

引用0浏览0引用

53683 Remibrutinib Provides Sustained Improvement in Itch Severity in Patients with Chronic Spontaneous Urticaria: Phase 2b Open-Label Extension Study

Robert Snyder, Alexander Greiner, Vipul Jain,Ana Maria Giménez-Arnau,Karine Lheritier,Pauline Walsh,Ivan Nikolaev,Sibylle Haemmerle,Lee Clore

Journal of the American Academy of Dermatologyno. 3 (2024): AB80

引用0浏览0引用

Remibrutinib Monotherapy Reduced Rescue Medication in Chronic Spontaneous Urticaria Patients: Findings from a Phase 2b Extension Study

Lee Clore,Warner Carr,Jeffrey Tillinghast,Vipul Jain, John Reed, Petra Staubach,Karine Lheritier,Pauline Walsh,Ivan Nikolaev,Sibylle Haemmerle,Ana Maria Gimenez-Arnau

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2024): AB6-AB6

引用0浏览0引用

Time to Relapse During Treatment-Free Follow-Up Without Remibrutinib in Patients with Chronic Spontaneous Urticaria: Subgroup Analysis by Baseline Immunoglobulin-E Levels and Chronic Urticaria Index Status from a Phase 2b Extension Study

Alexander Greiner,Vipul Jain,Ana Gimenez-Arnau,Jeffrey Tillinghast,Karine Lheritier,Sibylle Haemmerle,Pauline Walsh,Ivan Nikolaev,Robert Snyder

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2024): AB266-AB266

引用0浏览0引用

52859 Time to First Relapse During Treatment-Free Follow-Up Without Remibrutinib in Patients with Chronic Spontaneous Urticaria (CSU): Subgroup Analysis by Baseline Disease Status and CSU Duration from a Phase 2b Extension Study

Alexander Greiner,Vipul Jain,Ana Maria Giménez-Arnau,Jeffrey Tillinghast,Karine Lheritier,Sibylle Haemmerle,Pauline Walsh,Ivan Nikolaev, Robert Snyder

Journal of the American Academy of Dermatologyno. 3 (2024): AB340

引用0浏览0引用

52251 Remibrutinib Reduces CSU Symptoms and Rescue Medication Use in Patients with Chronic Spontaneous Urticaria Despite Absence of Background Medication

Lee Clore,Warner Carr,Jeffrey Tillinghast, Vipul Jain, John Reed, Petra Staubach, Dr, Karine Lheritier,Pauline Walsh,Ivan Nikolaev,Sibylle Haemmerle,Ana Maria Giménez-Arnau

Journal of the American Academy of Dermatologyno. 3 (2024): AB81

引用0浏览0引用

52636 Remibrutinib Improves Hive Severity in Patients with Chronic Spontaneous Urticaria: 52-Week Results from a Phase 2b Extension Study

Robert Snyder,Warner Carr,Jeffrey Tillinghast, Vipul Jain, Karine Lheritier,Pauline Walsh,Ivan Nikolaev,Sibylle Haemmerle,Ana Maria Giménez-Arnau

Journal of the American Academy of Dermatologyno. 3 (2024): AB297

引用0浏览0引用

42939 Remibrutinib Treatment Improves Itch and Sleep in Chronic Spontaneous Urticaria Patients: Phase 2b Study Results

Connie Hsu,Robert Snyder,Lee Clore,Vipul Jain,Ana Gimenez-Arnau,Karine Lheritier,Pauline Walsh,Sibylle Haemmerle,Michael Wells,Ivan Nikolaev,Marcus Maurer

Journal of the American Academy of Dermatology（2023）

引用0浏览0引用

Remibrutinib Improves Chronic Spontaneous Urticaria in Patients Irrespective of Previous Anti-IgE Treatment: Results From a Phase 2b Study

Alexander Greiner,Sridhar Guduri,Jeffrey Leflein,Sibylle Haemmerle,Karine Lheritier,Pauline Walsh,Ivan Nikolaev,Ana Giménez-Arnau,Marcus Maurer

Journal of Allergy and Clinical Immunologyno. 2 (2023): AB131-AB131

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn